NCT01406925View on ClinicalTrials.gov

Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

June 30, 2007

Conditions
Fecal Incontinence
Interventions
DRUG

Placebo control

Placebo cream

DRUG

NRL001 cream

Cream for single-dose intra-anal application

Trial Locations (1)

Unknown

University Hospital MHAPT Zaritza Johanna, Sofia

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY

NCT01406925 - Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers | Biotech Hunter | Biotech Hunter